ABSTRACT NUMBER: ESOC2026LB84 SERUM GFAP AFTER FIRST-ONSET TRANSIENT ISCHEMIC ATTACK: A PILOT CASE CONTROL STUDY
Reza Mosaddeghi-Heris, Saba Ghaffari, Sarvin Sanaie, Mehdi Yousefi, Behnaz Ahmadi, Amirreza Naseri, Samad Shams Vahdati · 2026
Read ABSTRACT NUMBER: ESOC2026LB84 SERUM GFAP AFTER FIRST-ONSET TRANSIENT ISCHEMIC ATTACK: A PILOT CASE CONTROL STUDY by Reza Mosaddeghi-Heris, Saba Ghaffari, Sarvin Sanaie, Mehdi Yousefi, Behnaz Ahmadi, Amirreza Naseri, Samad Shams Vahdati (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145007.txt.
Description
Reza Mosaddeghi-Heris and co-authors test a blood marker of brain cell injury after a first transient ischemic attack, in a 2026 conference abstract. A TIA is a brief stroke-like spell that leaves no dead tissue on scans. The marker, GFAP, spills from astrocytes when they are hurt. Fourteen patients seen within a day of symptoms were compared with fourteen healthy volunteers.
Marker levels ran about three times higher in patients. A cutoff near 2.3 units sorted the groups with fair accuracy. Women in the patient group showed higher levels than men. Levels did not predict function at six months. The authors call the pilot a hint of hidden injury and urge larger studies.
Catalog record
| CREATOR | Reza Mosaddeghi-Heris, Saba Ghaffari, Sarvin Sanaie, Mehdi Yousefi, Behnaz Ahmadi, Amirreza Naseri, Samad Shams Vahdati |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |